BMRN

NASDAQ

BioMarin Pharmaceutical, Inc. · Healthcare · Biotechnology

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$10.01B

PE Ratio

30.2576

EV to Ebitda

10.5388

Earnings Yield

3.31%

Revenue (TTM)

$3.24B

Net Income (TTM)

$348.9M

Revenue (Annual YoY Growth)

14.18%

Revenue (Quarterly YoY Growth)

21.24%

Profit Margin

10.76%

Return on Equity

5.89%

Debt to Equity Ratio

0.1056

Dividend Yield

0.00%

All fundamentals

Core10 fields›

Market Cap$10.01B

Revenue TTM$3.24B

Shares Outstanding192.3M

Float185931297

Float Short5.24%

Days To Cover5.7867626605

Short Interest10077755.0

Insider Ownership1.21%

Relative Strength29.2

GARP1866

Growth Estimates17 fields›

Revenue Growth (Annual)14.18%

Revenue Growth (Quarterly YoY)21.24%

Operating Revenue Growth (Annual)0.10981

Operating Revenue Growth (Quarterly YoY)0.154292

3-Year Revenue Growth16.55%

5-Year Revenue Growth11.97%

EPS Growth (Annual)-18.24%

EPS Growth (Quarterly YoY)-137.57%

3-Year EPS Growth Rate34.05%

5-Year EPS Growth Rate-16.79%

LT EPS Growth Estimates25.26%

EBITDA Growth (Annual)55.19%

EBITDA Growth (Quarterly YoY)-25.63%

CFO Growth (Annual)44.54%

CFO Growth (Quarterly YoY)-46.32%

FCF Growth (Annual)50.82%

FCF Growth (Quarterly YoY)-65.79%

Operations28 fields›

Revenue TTM$3.24B

Gross Margin TTM77.42%

Gross Margin (Quarterly)68.65%

R&D % of Revenue TTM21.62%

R&D Expenses TTM$701.0M

Operating Margin TTM25.21%

Operating Margin (Quarterly)11.16%

Operating Expenses TTM$1.69B

Profit Margin TTM10.76%

Profit Margin (Quarterly)-5.20%

Net Income TTM$348.9M

EPS TTM1.7817

EPS (Quarterly)-0.2423

EBIT Margin TTM25.21%

EBIT Margin (Quarterly)11.16%

EBITDA Margin TTM27.66%

EBITDA Margin (Quarterly)13.44%

EBITDA TTM$896.7M

CFO % of Revenue TTM25.54%

CFO % of Revenue (Quarterly)11.13%

CFO TTM$828.0M

Cash Margin24.93%

Capex % of Revenue TTM3.42%

Capital Expenditures$111.0M

FCF % of Revenue TTM22.12%

FCF % of Revenue (Quarterly)6.32%

FCF TTM$717.0M

Fundamental Score7

Efficiency6 fields›

ROE5.89%

ROA4.74%

ROIC5.33%

CROCI10.95%

Stock Comp % (Quarterly)5.24%

Stock Comp % TTM5.60%

Valuation19 fields›

P/E (TTM)30.2576

P/E Forward10.5149

P/E Ex-Cash25.7033

P/S Forward2.7056

PEG Forward0.0571

P/CFO12.6608

P/FCF14.6204

EV/EBITDA (TTM)10.5388

EV/EBITDA Forward9.4208

EV/Revenues (TTM)2.9151

EV/Revenues Forward2.4661

EV/CFO12.6941

EV/FCF (TTM)13.1802

Price To Book1.7033

Price to Tangible Book3.8598

Earnings Yield3.31%

FCF Yield6.84%

Dividend Yield0.00%

Value Score3

Relative to Industry10 fields›

Relative Gross Margin (Quarterly)0.8796

Relative P/E2.0654

Relative P/S0.5271

Relative P/B0.3817

Relative Earnings Yield0.4842

Relative Dividend Yield0

Relative ROE0.1765

Relative ROA0.268

Relative ROIC0.2187

Relative Debt to Equity0.3092

Liquidity15 fields›

Cash Per Share8.1155

Current Ratio5.1786

Cash & ST Assets$1.56B

Total Debt$634.3M

Goodwill & Intangibles$507.0M

Total Assets$7.59B

Total Liabilities$1.51B

Shareholders Equity$6.09B

Debt to Equity0.1056

Debt to Assets8.47%

Interest Expense$10.9M

Times Interest Earned74.9766

CFO to Debt (TTM)1.3247

Debt to EBITDA (TTM)0.697

Goodwill % of Assets6.68%

Yields4 fields›

Dividend Yield0.00%

Earnings Yield3.31%

Buyback Yield-0.14%

Shareholder Yield-0.18%

Options Flow8 fields›

Call Volume1026

Put Volume776

Put/Call Ratio0.7563352826510721

Call $ Volume279179

Put $ Volume273517

Put/Call $ Ratio0.9797191049470053

Call OI28346

Put OI9622